Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 13 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
121 32.0 months Advanced Ovarian cancer 3 Chemotherapy
Hôpital Hôtel-Dieu France 11/2006
Treatment Details: Patients: This phase II trial involved 104 women with advanced ovarian cancer that had relapsed. All patients had been pretreated with platinum and taxane. The median age was 61, ranging f
 
122 32.0 months Advanced ovarian cancer 4 Chemotherapy
Istituto Nazionale Tumori Italy 6/2008
Treatment Details: Patients: This phase II study involved 26 women with advanced ovarian cancer. Their median age was 77, ranging from 70 to 84 years of age. They had not received any prior treatment for the
 
123 32.0 months Advanced ovarian cancer or primary peritoneal cancer 4 Biologic therapy
Chemotherapy
Institut Gustave-Roussy France 6/2008
Treatment Details: Patients: This phase III study involved 762 women with ovarian or peritoneal cancer. The majority (690) had ovarian cancer. The median age of the patients was 59, ranging from 25 to 86 ye
 
124 31.9 months Metastatic breast cancer 5 Chemotherapy
Mount Vernon Hospital United Kingdom 7/2010
Treatment Details: Patients: This study involved female patients with locally recurrent or metastatic breast cancer. Patients were divided into 3 separate treatment groups. Group A consisted of 241 patients
 
125 31.5 months Advanced primary epithelial ovarian 4 Chemotherapy
Gynecologic Oncology Associates United States 7/2013
Treatment Details: Patients: This phase 2 study involved 88 previously untreated advanced primary epithelial ovarian, fallopian tube, or peritoneal carcinoma patients with a median age of 59 years. Treatme
 
126 31.4 months HER2-positive metastatic breast cancer 4 Biologic therapy
Chemotherapy
Immunotherapy
The University of Texas MD Anderson Cancer Center United States 9/2013
Treatment Details: Patients: This study involved 10 HER2-positive metastatic breast cancer patients with a median age of 46.5 years. One patient was male. Treatment: Patients were treated with high dose
 
127 31.2 months metastatic breast cancer 4 Biologic therapy
Chemotherapy
Hospital Saint Louis France 7/2005
Treatment Details: Patients: This Phase II study involved 186 women with metastatic breast cancer. Ninety-two women (median age 53) were randomly assigned into Group A, and ninety-four (median age 55) were pla
 
128 31.0 months Metastatic breast cancer 4 Chemotherapy
Hospital Clinico Universitario Spain 1/2003
Treatment Details: Patients: This Phase II study involved 81 patients with metastatic breast cancer. Treatment: The treatment consisted of the administration of the drugs, doxorubicin (adriamycin) and docet
 
129 30.9 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Unità Operativa Oncologia Medica Universitaria Italy 9/2010
Treatment Details: Patients: This study involved 57 metastatic colorectal cancer patients with a median age of 61 years and 60% male. Treatment: Patients were treated with the biologic agent bevacizumab a
 
130 30.8 months Metastatic breast cancer 5 Biologic therapy
Chemotherapy
Mount Vernon Hospital United Kingdom 7/2010
Treatment Details: Patients: This study involved female patients with locally recurrent or metastatic breast cancer. Patients were divided into 3 separate treatment groups. Group A consisted of 241 patients
 
Page 13 of 187  | Previous Page  | Next Page